Loading...

TTNP TITAN PHARMACEUTICALS INC Capital Structure Changes 8-K Filing

TTN

TTNP

TITAN PHARMACEUTICALS INC

(TTNP)

2023 8-K

Show Summary

Summary

Equity Offerings

Merger of Equals

Equity Offerings

Nasdaq Compliance

Management Changes

Nasdaq Compliance Issues

Management Change

CEO Resignation

Merger Announcement

Resignations and Appointments

Restatement of Financial St...

Equity Issuance

Agreement with Brian Crowley

Compliance with Nasdaq list...

Resignation of Brian Crowley

Reverse Stock Split

Reverse Stock Split

Notice from Nasdaq

Board of Directors Election

Private Placement and Purch...

Asset Purchase Agreement

Asset Purchase Agreement

Annual Meeting of Stockholders

Delisting Notice

External Links:

Titan Pharmaceuticals received notice from Nasdaq granting continued listing subject to compliance with stockholders equity and bid price requirements.

AI Assistant

TITAN PHARMACEUTICALS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.